Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening

Clement L. Ren*, Aliza K. Fink, Kristofer Petren, Drucy S. Borowitz, Susanna A. McColley, Don B. Sanders, Margaret Rosenfeld, Bruce C. Marshall

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

72 Scopus citations


BACKGROUND AND OBJECTIVES: Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome (CRMS) describes asymptomatic infants with a positive cystic fibrosis (CF) newborn screen (NBS) but inconclusive diagnostic testing for CF. Little is known about the epidemiology and outcomes of CRMS. The goal of this study was to determine the prevalence, clinical features, and short-term outcomes of infants with CRMS. METHODS: We analyzed data from the US CF Foundation Patient Registry (CFFPR) from 2010 to 2012. We compared demographic, diagnostic, anthropometric, health care utilization, microbiology, and treatment characteristics between infants with CF and infants with CRMS. RESULTS: There were 1983 infants diagnosed via NBS between 2010 and 2012 reported to the CFFPR. By using the CF Foundation guideline definitions, 1540 and 309 infants met the criteria for CF and CRMS, respectively (CF:CRMS ratio = 5.0:1.0). Of note, 40.8% of infants with CRMS were entered into the registry with a clinical diagnosis of CF. Infants with CRMS tended to have normal nutritional indices. However, 11% of infants with CRMS had a positive Pseudomonas aeruginosa respiratory tract culture in the first year of life. CONCLUSIONS: CRMS is a common outcome of CF NBS, and some infants with CRMS may develop features concerning for CF disease. A substantial proportion of infants with CRMS were assigned a clinical diagnosis of CF, which may reflect misclassification or clinical features not collected in the CFFPR.

Original languageEnglish (US)
Pages (from-to)e1386-e1392
Issue number6
StatePublished - Jun 1 2015

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening'. Together they form a unique fingerprint.

Cite this